The anti-colitis mechanism of pinocembrin might be associated with improving the disturbed gut microbiota composition, suppressing TLR4/MD2/NF-κB signaling cascades, and preserving intestinal barrier integrity. This evidence concerns the gene TLR4 and colitis.